Terlizzese M - Search Results

1

A deamidated interferon-β variant binds to integrin αvβ3.

Mastrangeli R, D'amici F, D'Acunto CW, Fiumi S, Rossi M, Terlizzese M, Palinsky W, Bierau H. Mastrangeli R, et al. Among authors: terlizzese m. Cytokine. 2018 Apr;104:38-41. doi: 10.1016/j.cyto.2018.01.024. Epub 2018 Feb 6. Cytokine. 2018. PMID: 29414325

2

In vitro biological characterization of IFN-β-1a major glycoforms.

Mastrangeli R, Rossi M, Mascia M, Palinsky W, Datola A, Terlizzese M, Bierau H. Mastrangeli R, et al. Among authors: terlizzese m. Glycobiology. 2015 Jan;25(1):21-9. doi: 10.1093/glycob/cwu082. Epub 2014 Aug 11. Glycobiology. 2015. PMID: 25117008

3

Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®.

Magnenat L, Palmese A, Fremaux C, D'Amici F, Terlizzese M, Rossi M, Chevalet L. Magnenat L, et al. Among authors: terlizzese m. MAbs. 2017 Jan;9(1):127-139. doi: 10.1080/19420862.2016.1259046. MAbs. 2017. PMID: 27854156 Free PMC article.

4

In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.

Terlizzese M, Simoni P, Antonetti F. Terlizzese M, et al. J Interferon Cytokine Res. 1996 Dec;16(12):1047-53. doi: 10.1089/jir.1996.16.1047. J Interferon Cytokine Res. 1996. PMID: 8974008

5

A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis.

Antonetti F, Finocchiaro O, Mascia M, Terlizzese MG, Jaber A. Antonetti F, et al. Among authors: terlizzese mg. J Interferon Cytokine Res. 2002 Dec;22(12):1181-4. doi: 10.1089/10799900260475696. J Interferon Cytokine Res. 2002. PMID: 12581490 Clinical Trial.

6

Relationship between specific alkylated bases and mutations at two gene loci induced by ethylnitrosourea and diethyl sulfate in CHO cells.

Bignami M, Vitelli A, Di Muccio A, Terlizzese M, Calcagnile A, Zapponi GA, Lohman PH, den Engelse L, Dogliotti E. Bignami M, et al. Among authors: terlizzese m. Mutat Res. 1988 Jan;193(1):43-51. doi: 10.1016/0167-8817(88)90006-5. Mutat Res. 1988. PMID: 2827012

7

Cytotoxicity, mutations and SCEs induced by methylating agents are reduced in CHO cells expressing an active mammalian O6-methylguanine-DNA methyltransferase gene.

Bignami M, Terlizzese M, Zijno A, Calcagnile A, Frosina G, Abbondandolo A, Dogliotti E. Bignami M, et al. Among authors: terlizzese m. Carcinogenesis. 1987 Oct;8(10):1417-21. doi: 10.1093/carcin/8.10.1417. Carcinogenesis. 1987. PMID: 3115613

8

Induction kinetics of mutations at two genetic loci, DNA damage and repair in CHO cells after different exposure times to N-ethyl-N-nitrosourea.

Dogliotti E, Vitelli A, Terlizzese M, Di Muccio A, Calcagnile A, Saffiotti U, Bignami M. Dogliotti E, et al. Among authors: terlizzese m. Carcinogenesis. 1987 Jan;8(1):25-31. doi: 10.1093/carcin/8.1.25. Carcinogenesis. 1987. PMID: 3026680

9

Effects of buffer composition on water stability of alkylating agents. The example of N-ethyl-N-nitrosourea.

Tosato ML, Terlizzese M, Dogliotti E. Tosato ML, et al. Among authors: terlizzese m. Mutat Res. 1987 Aug;179(2):123-33. doi: 10.1016/0027-5107(87)90302-2. Mutat Res. 1987. PMID: 3614242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters